Pharma sector can be a market performer in next fiscal year: Sajiv Dhawan, JV Capital

In a chat with ET Now, Sajiv Dhawan, MD, JV Capital Services, shares his views on pharma sector.

ET Now: The new pharma policy has been approved. What would it mean for some of these pharma majors?

Sajiv Dhawan: The negative sentiment which was there would have happened yesterday but you have seen the stocks have a phenomenal run-up in the last one year. The market is clearly rewarding sectors which are moving.

If stocks like Lupin or Cipla corrected on the back of their good results, this policy and the price affect, it would be a short-term impact. But again, enough buyers would come into that sector. So, pharma as a sector, is still likely to be a market performer or even an outperformer in the next financial year.